Zainidip in Renal Artery Stenosis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 149 participants.

Also called NCT02594410

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 149 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02594410
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02594410. Allocation not applicable; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2014-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Zainidip in Renal Artery Stenosis
Condition
Hypertension
Intervention (Device)
stent
Intervention (Drug)
Aspirine
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Lercanidipine
Lead sponsor
Lee's Pharmaceutical Limited (class: industry)

Record details

Record id
cardio:ct-nct02594410
Content hash
7e721076f479059f248d923ef3469ecf2b26a46150e085788a2fc1b15b7e75d1